SCHEMBL1805574

SCHEMBL1805574

CCCc1ccc(-c2noc3c2CCc2cc(COC(=O)C4CNC4)ccc2-3)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 16/20 0.63
S1PR3 Q99500 11/20 0.46
CYP3A4 P08684 1/20 0.40
CYP2C8 P10632 1/20 0.40
KCNH2 Q12809 1/20 0.40
MAPT P10636 3/20 0.40
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 1/20 0.40
NFKB1 P19838 1/20 0.40
RAB9A P51151 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1809788 0.81 S1PR1 (0.64) S1PR1S1PR3CYP3A4NPC1RAB9A
SCHEMBL1805571 0.78 S1PR1 (1.00) S1PR1S1PR3CYP3A4CYP2C8KCNH2
SCHEMBL1812863 0.75 S1PR1 (0.62) S1PR1S1PR3CYP3A4CYP2C8KCNH2
SCHEMBL1811348 0.74 S1PR1 (0.61) S1PR1S1PR3MAPTALDH1A1KDM4E
SCHEMBL1811956 0.73 S1PR1 (0.74) S1PR1S1PR3CYP2C8CYP1A2CYP2D6
SCHEMBL1808108 0.72 RAB9A (0.45) MAPTALDH1A1KDM4ENPC1NFKB1
SCHEMBL1813648 0.72 S1PR1 (0.59) S1PR1S1PR3CYP3A4CYP2C8KCNH2
SCHEMBL1812823 0.72 S1PR1 (0.86) S1PR1S1PR3CYP3A4CYP2C8KCNH2
SCHEMBL17264640 0.69 S1PR1 (0.57) S1PR1CYP3A4MAPTALDH1A1KDM4E
SCHEMBL1814073 0.69 S1PR1 (0.71) S1PR1S1PR3CYP3A4MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2493866-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS Bristol-Myers Squibb Company (US) 2012-09-05 EP disclosed
WO-2011059784-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2011-05-19 WO disclosed